CoMentis' Series A Round

CoMentis raised a round of funding on February 20, 2006.

CoMentis is focused on developing drugs to treat various central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company covers the research and development spectrum …

Articles about CoMentis' Series A Round: